Select Medical Holdings Corporation (NYSE:SEM) Shares Bought by SG Americas Securities LLC

SG Americas Securities LLC grew its stake in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 151.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 37,684 shares of the health services provider's stock after buying an additional 22,671 shares during the period. SG Americas Securities LLC's holdings in Select Medical were worth $629,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. GAMMA Investing LLC raised its stake in Select Medical by 217.4% in the 1st quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider's stock worth $109,000 after acquiring an additional 4,453 shares during the last quarter. Wedge Capital Management L L P NC raised its stake in shares of Select Medical by 16.1% in the first quarter. Wedge Capital Management L L P NC now owns 137,110 shares of the health services provider's stock worth $2,290,000 after purchasing an additional 19,061 shares during the last quarter. NorthCrest Asset Manangement LLC purchased a new position in shares of Select Medical in the fourth quarter worth about $209,000. Phocas Financial Corp. purchased a new stake in Select Medical in the fourth quarter valued at approximately $1,877,000. Finally, Brucke Financial Inc. purchased a new stake in Select Medical in the fourth quarter valued at approximately $245,000. Hedge funds and other institutional investors own 89.48% of the company's stock.

Insider Buying and Selling

In related news, Director Parvinderjit S. Khanuja purchased 21,000 shares of the business's stock in a transaction that occurred on Monday, May 5th. The stock was bought at an average price of $15.02 per share, with a total value of $315,420.00. Following the acquisition, the director now owns 65,089 shares in the company, valued at $977,636.78. The trade was a 47.63% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO David S. Chernow sold 225,000 shares of the stock in a transaction on Monday, April 28th. The shares were sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the transaction, the chief executive officer now directly owns 714,516 shares in the company, valued at approximately $12,861,288. The trade was a 23.95% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several analysts have commented on SEM shares. Mizuho assumed coverage on shares of Select Medical in a research note on Wednesday, April 16th. They set an "outperform" rating and a $25.00 price objective for the company. Royal Bank Of Canada decreased their target price on shares of Select Medical from $23.00 to $19.00 and set an "outperform" rating for the company in a research report on Wednesday, May 7th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Select Medical presently has an average rating of "Moderate Buy" and an average target price of $26.00.

Select Medical Stock Performance

NYSE:SEM traded down $0.15 during trading hours on Wednesday, reaching $14.95. The company had a trading volume of 1,287,888 shares, compared to its average volume of 976,374. The firm has a market cap of $1.92 billion, a PE ratio of 11.15, a price-to-earnings-growth ratio of 0.79 and a beta of 1.34. Select Medical Holdings Corporation has a 1-year low of $14.03 and a 1-year high of $40.98. The business's 50 day moving average price is $15.44 and its 200-day moving average price is $17.29. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.16 and a quick ratio of 1.16.

Select Medical (NYSE:SEM - Get Free Report) last posted its earnings results on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.01). The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.40 billion. Select Medical had a net margin of 2.81% and a return on equity of 11.04%. The business's revenue for the quarter was down 24.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.75 earnings per share. Research analysts forecast that Select Medical Holdings Corporation will post 1.17 EPS for the current year.

Select Medical announced that its board has approved a stock buyback program on Thursday, May 1st that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the health services provider to repurchase up to 42.6% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's management believes its shares are undervalued.

Select Medical Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were paid a $0.0625 dividend. The ex-dividend date of this dividend was Thursday, May 15th. This represents a $0.25 annualized dividend and a dividend yield of 1.67%. Select Medical's dividend payout ratio is presently 18.66%.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.